REMICADE® can change the course of
rheumatoid arthritis (RA)
If you've been diagnosed with moderately to severely active RA, REMICADE® may be able to help. In clinical trials, REMICADE®, when taken with methotrexate, has been shown to:
- Quickly relieve pain and stiffness—in as few as 2 weeks in some patients
- Help stop further joint damage caused by RA. For some patients, it may even help stop damage before it starts
- Improve your ability to do everyday activities, like getting out of bed, dressing or washing, and walking. Individual results may vary
- Provide infrequent dosing, customized according to your weight
Individual results may vary.
As with any medication, it's important to keep your doctor informed about the impact of REMICADE® on your symptoms and about any side effects you may be having.
More about REMICADE®
REMICADE® has been used to treat more than 1.3 million patients worldwide who have inflammatory conditions such as plaque psoriasis, rheumatoid arthritis, psoriatic arthritis, adult and pediatric Crohn's disease, ulcerative colitis, and ankylosing spondylitis.
REMICADE® is given as a 2-hour IV infusion by a healthcare professional, so someone is always there during your treatment, and for a period of time afterward, to monitor you for side effects. After the 3 starter doses, you may need REMICADE® only once every 8 weeks—as few as 6 times a year.
REMICADE®, like other medicines that affect your immune system, can cause serious side effects. Please read the Important Safety Information and the Medication Guide  for REMICADE®, and discuss any questions or symptoms with your doctor.
Ask your rheumatologist if REMICADE® is right for you.